Bio-pharma companies like Amgen are making history, transforming the landscape of treatment with diverse and personalized biotherapeutics. At Danaher Corporation, we believe that innovation shapes our future. Our unique operating companies working in parallel to provide end-to-end solutions and services in support of your drug discovery and development journey.
We invite you to join our subject matter experts in engaging conversations about the latest advancements in imaging, automation, analytical technologies, and essential raw materials, all aimed at enhancing your understanding of therapy mechanisms.

Molecular Devices
Increasing the Throughput of Organoid- Based Assays
Presentation

Beckman Coulter Life Sciences
Experts in fluid transferology
Presentation

SCIEX
Comprehensive characterization of protein therapeutics
Presentation

Phenomenex
Analysis of CQAs on Biotherapeutics leveraging Phenomenex’s bioZen LC Columns
Presentation

Beckman Coulter Life Sciences
Automating ELISA Assays with Biomek i-Series Workstations
Presentation

Leica Microsystems
AIVIA: Accelerating Microscopy Image Analysis with AI
Presentation

Abcam | Beckman Coulter Life Sciences | Molecular Devices
Enabling End-to-End Solutions for ELISA Screening
Presentation